Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy

(2009) Lance P. Christensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

(2008) Paul Milliez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart

(2008) M. Maczewski et al.   CARDIOVASCULAR RESEARCH

Potential novel pharmacological therapies for myocardial remodelling

(2008) U. Landmesser et al.   CARDIOVASCULAR RESEARCH

Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcription

(2008) Wenjie He et al.   CARDIOVASCULAR RESEARCH

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET